Abstract
Biliary atresia is a rare inflammatory sclerosing obstructive cholangiopathy that initiates
in infancy as complete choledochal blockage and progresses to the involvement of intrahepatic biliary
epithelium. Growing evidence shows that biliary atresia is not a single entity with a single etiology
but a phenotype resulting from multifactorial events whose common path is obliterative cholangiopathy.
The etiology of biliary atresia has been explained as resulting from genetic variants,
toxins, viral infection, chronic inflammation or bile duct lesions mediated by autoimmunity, abnormalities
in the development of the bile ducts, and defects in embryogenesis, abnormal fetal or prenatal
circulation and susceptibility factors. It is increasingly evident that the genetic and epigenetic
predisposition combined with the environmental factors to which the mother is exposed are potential
triggers for biliary atresia. There is also an indication that a progressive thickening of the arterial
middle layer occurs in this disease, suggestive of vascular remodeling and disappearance of the interlobular
bile ducts. It is suggested that the hypoxia/ischemia process can affect portal structures in
biliary atresia and is associated with both the extent of biliary proliferation and the thickening of the
medial layer.
Keywords:
Biliary atresia, hypoxia, ischemia, etiology, genetics, epigenetics, gut microbiota, immunity.
Graphical Abstract
[41]
Durkin N, Deheragoda M, Davenport M. Prematurity and biliary atresia: A 30-year observational study. 2017; 33(12): 1355-61.
[50]
Oetzmann von Sochaczewski C, Pintelon I. Experimentally induced biliary atresia by means of rotavirus-infection is directly linked to severe damage of the microvasculature in the extrahepatic bile duct. Anat Rec (Hoboken) 2019; 302(5): 818-24.
[57]
Santos JL, Carvalho E, Bezerra JA. Advances in biliary atresia: From patient care to research. Brazilian journal of medical and biological research. Rev Bras Pesqui Med Biol 2010; 43(6): 522-7.
[90]
Cofer ZC, Cui S. Methylation microarray studies highlight pdgfa expression as a factor in biliary atresia. PLoS One 2016; 11(3): e0151521.
[112]
Feldman AG, Tucker RM, Fenner EK, Pelanda R, Mack CL. B cell deficient mice are protected from biliary obstruction in the rotavirus-induced mouse model of biliary atresia. PLoS One 2013; 8(8): e73644.
[118]
Calmus Y, Poupon R. Shaping macrophages function and innate immunity by bile acids: Mechanisms and implication in cholestatic liver diseases. Clin Res Hepatol Gastroenterol 2014; 38(5): 550-6.
[125]
Desmet VJ. Ductal plates in hepatic ductular reactions. Hypothesis and implications. II. Ontogenic liver growth in childhood. Virchows Arch 2011; 458(3): 261-70.
[134]
Navabi N, Shivakumar P, Eds. Discovery of polyurethane chemicals as new etiopathogenic agents in biliary atresia. Hepatology WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA . 2019.
[142]
Jee J, Mourya R, Shivakumar P, Fei L, Wagner M, Bezerra JA. Cxcr2 signaling and the microbiome suppress inflammation, bile duct inju-ry, and the phenotype of experimental biliary atresia. PLoS One 2017; 12(8): e0182089.
[157]
Mohanty SK, Donnelly B, Temple H, Tiao GM. Rotavirus-induced mouse model to study biliary atresia and neonatal cholestasis. Methods Mol Biol 2019; 1981: 259-71.